# Reshape

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/reshape-aps

- Industry: Software
- Headquarters: Copenhagen, Denmark
- Website: www.reshapebiotech.com
- Total disclosed funding: $28M
- Latest round: Series A (Apr 9, 2024)
- Investors on record: 6

## About

Based in Denmark, and founded in 2018, Reshape ApS operates as a hardware and software firm. The company was founded by its CEO Carl-Emil Grøn Christensen, CTO Daniel Storgaard, and Magnus Nyborg Madsen. In April 2024, Reshpe ApS raised USD 20 million in series A funding led by Astanor Ventures, with participation from R7 Partners and 21st.Bio. Returning investors ACME Capital, Y Combinator, and individual investors also participated in the round.

Reshape develops and offers lab automation robots. The products and services offered by the company include a hardware and software-based Reshape imaging system for microbial assays; a Reshape media plate filler, which is an automatic plate filling equipment; and a Reshape analysis service, which is a machine-learning-based data analysis platform that analyzes test results.

The company generates revenue by offering its services on a subscription-based pricing plan. The plans include a startup lab (240 petri dishes per month), an R&D screening platform (960 microtiter plates per month), and a full-scale high-throughput lab (7,200 petri dishes per month).

Reshape ApS plans to use the April 2024 funding to expand its business in the U.S. and enhance its R&D for agricultural, industrial, and biotech organizations.

## Funding rounds

- Series A, Apr 9, 2024, $20M — Y Combinator, ACME Capital, R7 Partners, Astanor Ventures, 21st.Bio
- Seed, Feb 9, 2023, $8.1M — Y Combinator, FundersClub, ACME Capital

## Investors

- Y Combinator (https://capitalatlas.ai/funds/y-combinator) — Seed, Series A
- FundersClub (https://capitalatlas.ai/funds/fundersclub) — Seed
- ACME Capital (https://capitalatlas.ai/funds/acme-capital) — Seed, Series A
- R7 Partners (https://capitalatlas.ai/funds/r7-partners) — Series A
- Astanor Ventures (https://capitalatlas.ai/funds/astanor-ventures) — Series A
- 21st.Bio — Series A